| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $21.7M | +619.5% |
| SG&A Expense | $75.3M | +288.5% |
| Operating Income | -$97.0M | -332.9% |
| Pre-tax Income | -$740.3M | -1573.4% |
| Income Tax | -$279K | — |
| Net Income | -$739.5M | -1571.6% |
| EPS (Basic) | -$2.80 | +67.3% |
| EPS (Diluted) | -$2.80 | +67.3% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.1M | — |
| Current Assets | $86.3M | +1167.6% |
| Total Assets | $302.6M | +1662.1% |
| Current Liabilities | $122.2M | +71.8% |
| Long-term Debt | $9.0M | -77.1% |
| Total Liabilities | $145.6M | +84.6% |
| Stockholders' Equity | $157.0M | +354.3% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.8M | -275.5% |
| Capital Expenditures | $11.6M | — |
| Investing Cash Flow | -$47.2M | — |
| Financing Cash Flow | $197.3M | +1015.1% |
| Free Cash Flow | -$77.4M | -340.6% |